Veraxa Biotech Holding AG (VRXA) Non-Current Assets (2024 - 2025)

Veraxa Biotech Holding AG (VRXA) has reported Non-Current Assets for 2 consecutive years, with $97.5 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Non-Current Assets rose 7.91% year-over-year to $97.5 million; the trailing twelve-month figure through Dec 2025 stood at $97.5 million (up 7.91% YoY), and the FY2025 full-year result was $97.5 million, up 7.91% from the prior year.
• Non-Current Assets climbed to $97.5 million in Q4 2025 per VRXA's latest filing, from $90.4 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $97.5 million in Q4 2025 to a low of $90.4 million in Q4 2024.